-
Zelensky warns airlines Russian skies not safe due to Ukraine drones
-
Confident Gauff reaches US Open 2nd round with straight-set win
-
UK vows anti-settler measures as Israel warns of retaliation
-
US postal whistleblower warns ballot system could disrupt midterms
-
New pro Koivun among US Presidents Cup picks
-
John Ternus takes over as Apple enters era of AI, foldable phones
-
G20 finance leaders close talks marked by US welcoming Russia
-
Second-ranked Rybakina eases into US Open 2nd round
-
From Hollywood to big time tennis: teen makes US Open debut
-
Man City sign Fernandez, Ndiaye as Premier League clubs set new spending record
-
Man City secure Premier League record deal to sign Fernandez
-
Alcaraz aims to step it up in round two of US Open title defense
-
Kaepernick says NFL 'blackballing me' decade after protest
-
Honduran judge drops corruption charges against ex-leader Hernandez
-
Atletico loan David from Juve, send Lemar to Elche
-
Mudryk joins Spurs on loan from Chelsea after doping ban ends
-
Chelsea 'keeper Sanchez makes deadline-day move to Como
-
What's next after judge strikes down New York's landmark climate fund law
-
Kroenke to buy baseball's Los Angeles Angels: statement
-
Cobolli claws out five-set victory at rain-hit US Open
-
US defends Trump's Venezuela oil deal
-
Ndiaye seizes 'chance of a lifetime' in Man City move
-
OpenAI to launch new model with 'stronger safeguards' after hack
-
Global bond sell-off, surging oil prices send markets into the red
-
Fans mourn 'bittersweet' final Ariana Grande gig in London
-
Zuckerberg, Musk make plea at G20 for more AI data centers
-
Norway's King Haakon VIII swears allegiance to constitution
-
'Discomfort' at G20 finance talks as US hosts Russian minister
-
Syria site infrastructure 'consistent with nuclear reactor': IAEA
-
Man City set to sign Fernandez for record fee, Ndiaye on deadline day
-
Juventus sign Woltemade, Sarr on loan from Premier League
-
Back-to-school in Cuba a grim day with shortages of everything
-
US strikes Iran in latest tit-for-tat attacks
-
Canadian minister says Russia's G20 presence sparked 'discomfort'
-
China's Xi arrives in Egypt as US sanctions threat looms over Iran links
-
IMF reaches agreement with Senegal on new $2.2 bn loan programme
-
Car bomb at Colombian police station kills one, injures 11
-
Germany blames Russia for airport drone incident, hits back with sanctions
-
Rain delays start of play on US Open
-
Iran president urges return to truce, hails Russian support
-
Man City agree blockbuster deal to sign Chelsea star Fernandez: reports
-
Aster and World Liberty Financial Launch USD1 RWA Boost: Phase 1, Offering 125M $WLFI + 6.25M USD1 in Rewards
-
Alkemya Metacore Secures $50M via Tokenised Equity to Scale Nickel Energy and Security Tech
-
Tronchon sprints to Vuelta stage 10 win, Mas keeps red jersey
-
Man City chase Fernandez, Arsenal sell Jesus on deadline day
-
Germany defender Rudiger announces international retirement
-
EU says Russian 'hybrid attacks' won't halt aid to Ukraine
-
Musk defends AI data centers, slams EU rules at G20
-
Explosives used in sabotage attack on German power lines
-
Activists blame Kenya for Ugandan opposition figure's plight
Modular Medical Appoints Industry Veteran Jeff Goldberg to Board of Directors
SAN DIEGO, CA / ACCESS Newswire / May 28, 2025 / Modular Medical, Inc. (Nasdaq:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch pump designed specifically to meet the needs of "almost-pumpers" with its user-friendly and affordable design, today announced the appointment of Jeff Goldberg to its Board of Directors. Mr. Goldberg brings decades of experience in health care, life sciences, and medical device leadership, including development of generic insulin. Mr. Goldberg began his work in medical technology alongside pioneering medical entrepreneur, and founder of MiniMed, Alfred E. Mann.
"We are pleased to welcome Jeff Goldberg to the Modular Medical board," said Jeb Besser, CEO of Modular Medical. "Jeff's unique background at the intersection of affordable drug-device combinations will be instrumental, as we advance our mission to simplify insulin delivery and improve diabetes care worldwide."
Mr. Goldberg currently serves as Chairman of Lannett Company, Inc., a generic pharmaceutical manufacturer where he has helped execute a post-restructuring turnaround. During his tenure, Lannett has made significant strides in launching a generic insulin product - progress that aligns closely with Modular Medical's commitment to innovation and affordability in diabetes care.
In addition to his work at Lannett, Mr. Goldberg previously served as President and CEO within Alfred E. Mann's incubator, IncuMed, where he oversaw multiple portfolio companies focused on drug-device combination products, including an insulin patch-pump program. His tenure with Mr. Mann's enterprises included pivotal roles in regulatory strategy, operations turnaround, and successful exits, underscoring his ability to guide early-stage technologies to commercial viability.
"Modular Medical is advancing a truly disruptive approach to insulin delivery," said Mr. Goldberg. "I'm excited to join the board and contribute to the Company's journey toward simplifying treatment for people living with diabetes, particularly as the industry shifts toward more accessible and patient-friendly solutions."
Mr. Goldberg also serves on the boards of several health-care and consumer-focused companies, including ATI Physical Therapy, Cano Health, and Eating Recovery Centers. He holds a JD from UCLA School of Law and an AB from Harvard College.
About Modular Medical
Modular Medical, Inc. (Nasdaq:MODD) is a development-stage medical device company that intends to launch the next generation of insulin delivery technology. Using its patented technologies, the Company seeks to eliminate the tradeoff between complexity and efficacy, thereby making top quality insulin delivery both affordable and simple to learn. Its mission is to improve access to the highest standard of glycemic control for people with diabetes taking it beyond "superusers" and providing "diabetes care for the rest of us."
Modular Medical was founded by Paul DiPerna, a seasoned medical device professional and microfluidics engineer. Prior to founding Modular Medical, Mr. DiPerna was the founder (in 2005) of Tandem Diabetes and invented and designed its insulin pump. More information is available at https://modular-medical.com.
CONTACT:
Jeb Besser
Chief Executive Officer
Modular Medical, Inc.
+1 (617) 399-1741
[email protected]
SOURCE: Modular Medical, Inc.
View the original press release on ACCESS Newswire
A.Clark--AT